We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wyeth v. Levine Decision Casts Doubt on FDA’s Labeling Authority
Wyeth v. Levine Decision Casts Doubt on FDA’s Labeling Authority
March 11, 2009
In a ruling that reduces the FDA’s drug-labeling authority from one of potentially preemptive power to one that merely sets a floor, which state courts and juries presumably may revise as individual cases arise, the U.S. Supreme Court’s decision in Wyeth v. Levine places primary responsibility for adequate labeling on drugmakers.